Previous work has not explored TROY's relationship with age; however, it is a tumor necrosis factor receptor superfamily member and has been implicated in cancer, vascular development in the brain, and blood–brain barrier functioning.29, 30. The gene discussed is TNFRSF19; the disease is cancer.